APPLICATION
ANDA074031
TYPE
ANDA
ORIGINAL APPROVAL
1994-03-25
LATEST ACTION
2008-09-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
TRIAZOLAMDiscontinued
TRIAZOLAM 0.125MG · TABLET · ORAL
TRIAZOLAMDiscontinued
TRIAZOLAM 0.25MG · TABLET · ORAL
Approval history
2008-09-18Labeling · Supplement 5AP
2004-03-18Labeling · Supplement 4AP
1997-03-27Labeling · Supplement 2AP
1994-07-06Manufacturing (CMC) · Supplement 1AP
1994-03-25OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.